Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Malignant Lymphoma |
Free Subscription
2 Am J Hematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Malignant Lymphoma is free of charge.
Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients
and/or patients with poor ECOG performance status with relapsed or refractory
large B-cell lymphoma after 2 or more lines of prior therapy.
Am J Hematol. 2024 Mar 19. doi: 10.1002/ajh.27283.
PubMed
Abstract available
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia.
Am J Hematol. 2024 Feb 5. doi: 10.1002/ajh.27227.
PubMed
Abstract available
Insulin-like Growth Factor II mRNA-binding Protein 3 is a Highly Sensitive Marker
for Intravascular Large B-cell Lymphoma: Immunohistochemical Analysis of 152
Pathology Specimens From 88 Patients.
Am J Surg Pathol. 2024 Mar 18. doi: 10.1097/PAS.0000000000002214.
PubMed
Abstract available
Introduction to a review series on the influence of the tumor microenvironment on
the pathogenesis of B-cell lymphomas.
Blood. 2024;143:1057-1058.
PubMed
Frontline Treatment of Mantle Cell Lymphoma.
Blood. 2024 Mar 18:blood.2023022352. doi: 10.1182/blood.2023022352.
PubMed
Abstract available
Golidocitinib favorable for relapsed/refractory T-cell lymphoma.
Cancer. 2024;130:1191-1192.
PubMed
The genetic landscape of histologically transformed marginal zone lymphomas.
Cancer. 2024;130:1246-1256.
PubMed
Abstract available
Efficacy of intravenous high-dose methotrexate in preventing relapse to the
central nervous system in R-CHOP(-like)-treated, high-risk, diffuse large B-cell
lymphoma patients and its effect on mortality: a systematic review and
meta-analysis.
Haematologica. 2024 Mar 14. doi: 10.3324/haematol.2023.284281.
PubMed
Abstract available
Validation of LymphGen classification on a 400-gene clinical next-generation
sequencing panel in diffuse large B-cell lymphoma: real-world experience from a
cancer center.
Haematologica. 2024 Mar 14. doi: 10.3324/haematol.2023.284565.
PubMed
Abstract available
Bendamustine and rituximab as first-line treatment for symptomatic splenic
marginal zone lymphoma: long-term outcome and impact of early unmeasurable
minimal residual disease attainment from the BRISMA/IELSG36 phase II study.
Haematologica. 2024 Mar 14. doi: 10.3324/haematol.2023.284109.
PubMed
Abstract available
Systemic diffuse large B-cell lymphoma involving the central nervous system have
high rates of defective antigen presentation and immune surveillance.
Haematologica. 2024 Mar 21. doi: 10.3324/haematol.2023.284600.
PubMed
Abstract available
Pushing the CART to the Finish Line: Integrating Radiation Therapy Into Chimeric
Antigen Receptor T-Cell Therapy Programs to Improve Outcomes for Patients With
Relapsed/Refractory Diffuse Large B-Cell Lymphoma.
Int J Radiat Oncol Biol Phys. 2024;118:1152-1158.
PubMed
Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate
cancers after diagnosis of primary cutaneous B-cell lymphoma: A SEER database
analysis.
J Am Acad Dermatol. 2024 Mar 19:S0190-9622(24)00505.
PubMed
Risk of Systemic Lymphoma in Patients with Cutaneous CD30+ Lymphoproliferative
Disorders: A Single Center Retrospective Cohort Analysis.
J Am Acad Dermatol. 2024 Mar 13:S0190-9622(24)00489.
PubMed
Phase II study of the novel antifolate agent pralatrexate in combination with the
histone deacetylase inhibitor romidepsin for the treatment of patients with
mature T-cell lymphoma.
Leuk Lymphoma. 2024 Mar 22:1-10. doi: 10.1080/10428194.2024.2329996.
PubMed
Abstract available
Progressive TP53 inactivation in an aggressive splenic diffuse red pulp small
B-cell lymphoma.
Leuk Lymphoma. 2024 Mar 22:1-5. doi: 10.1080/10428194.2024.2332508.
PubMed
Treatment outcome, toxicity, and quality of life of patients with
bronchus-associated lymphoid tissue lymphoma.
Leuk Lymphoma. 2024 Mar 20:1-12. doi: 10.1080/10428194.2024.2329328.
PubMed
Abstract available
Lymphoplasmacytic lymphoma and multiple myeloma coexisting in the same patient: a
case series and literature review.
Leuk Lymphoma. 2024 Mar 19:1-7. doi: 10.1080/10428194.2024.2332499.
PubMed
Abstract available
Chidamide enhances T-cell-mediated anti-tumor immune function by inhibiting
NOTCH1/NFATC1 signaling pathway in ABC-type diffuse large B-cell lymphoma.
Leuk Lymphoma. 2024 Mar 18:1-16. doi: 10.1080/10428194.2024.2328227.
PubMed
Abstract available
Treatment and survival for patients with localized primary ocular adnexal
extranodal marginal zone lymphoma.
Leukemia. 2024 Mar 19. doi: 10.1038/s41375-024-02227.
PubMed
"What's Lymphoma?" - Risks Posed by Immediate Release of Test Results to
Patients.
N Engl J Med. 2024;390:1064-1066.
PubMed
Thank you for your interest in scientific medicine.